# A Study to Investigate the Effect of JNJ-67953964 on Gastric Mucosal Integrity in Healthy Male and Female Participants

> **NCT04185051** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 76 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-67953964
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04185051
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-17
- **Primary completion:** 2021-04-21
- **Final completion:** 2021-05-05
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04185051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04185051, "A Study to Investigate the Effect of JNJ-67953964 on Gastric Mucosal Integrity in Healthy Male and Female Participants". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04185051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*